Abstract
Not so long ago, “Anaplastic Tumor” ranked among the top ten most common diagnoses in pathology departments around the World. That this is no longer true is in large measure attributable to the widespread use of IHC methods for the diagnosis of very poorly differentiated or anaplastic malignant tumors, whether as metastases or apparent primary lesions. In effect, IHC stains provide a sensitive method for the demonstration of characteristic cell products or structural proteins (antigens) that allow identification of cell lineage when morphologic features alone cannot do so. This chapter provides a concise and practical approach for the application of IHC methods to facilitate the diagnosis of tumors of unknown origin. Screening approaches employing selected panels of stains are described for common broad categories of tumors (carcinomas, sarcomas, lymphomas, etc.), together with “second-tier” stains to home in on a more specific diagnosis. Emphasis is on an efficient practical approach, that is both economical (using the minimum number of stains) and rapid (requiring of the least number of additional staining runs). For rapid reference many of the IHC stains and stain panels are presented in summary tables, without further detail of the typical patterns of reactivity of each antibody. However, all of the antibodies (stains) described in this chapter have been discussed previously in; further details may be found by recourse to individual organ and issue specific chapters throughout the book.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
SUGGESTED READING
General
Chu PG, Weiss LM. Keratin Expression in human tissues and neoplasms. Histopathol 2002;40:403–439.
Dabbs, DJ (ed). Diagnostic immunohistochemistry. Philadelphia, Churchill Livingston, 2006.
Nadji M, Nassiri M, Morales AR (eds). Efficient Tumor Immunohistochemistry: A Differential Diagnosis-driven Approach. Chicago, ASCP Press, 2006.
Taylor CR, Cote RJ (eds). Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. 3rd ed., Philadelphia, Saunders, 2006.
Unknown Tumor
Al-Nafussi A, Wong NA. Intra-abdominal spindle cell lesions: a review and practical aids to diagnosis. Histopathol 2001;38:387–402.
Anderson GG, Weiss LM. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl Immunohistochem Mol Morphol 2010;18:3–8.
Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathol 2006;48:13–21.
Bahrami A, Truong LD, Ro JY.Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med 2008;132:326–348.
Becher MW, Abel TW, Thompson RC, Weaver KD, Davis LE. Immunohistochemical analysis of metastatic neoplasms of the central nervous system. J Neuropathol Exp Neurol 2006;65:935–944.
Bender RA, Erlander MG. Molecular classification of unknown primary cancer. Semin Oncol 2009;36:38–43.
Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004;101:2006–2010.
Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: Biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211:1–9.
Cheuk W, Kwan MY, Suster S, Chan JK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001;125:228–231.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasm. Histopathol 2002;40:403–439.
Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathol 2003;43:1–16.
Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN, Oien KA. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005;11:3766–3772.
Gown AM, Yaziji H. Immunohistochemical analysis of carcinomas of unknown primary site. Pathol Case Rev 1999;4:250–259.
Heim-Hall J, Yohe SL. Application of immunohistochemistry to soft tissue neoplasms. Arch Pathol Lab Med 2008;132:476–489.
Krishnan C, George TI, Arber DA. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas. Appl Immunohistochem Mol Morphol 2007;15:1–7.
Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry; differential diagnosis between colonic and ovarian carcinomas as primary sited. Hum Pathol 1998;29:491–497.
Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 1999;52:283–290.
Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009;36:8–37.
Park SY, Kim KH, Kim JH, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 2007;131:1561–1567.
Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 2008;33:626–632.
Tot T. Review: Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002;38:758–763.
Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004;100:1776–1785.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Klipfel, N., Simental-Pizarro, R., Taylor, C.R. (2011). Tumors of Unknown Primary. In: Cheng, L., Bostwick, D. (eds) Essentials of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6043-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6043-6_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6042-9
Online ISBN: 978-1-4419-6043-6
eBook Packages: MedicineMedicine (R0)